Literature DB >> 17712690

Local understanding of an HIV vaccine and its relationship with HIV-related stigma in the Dominican Republic.

C Barrington1, L Moreno, D Kerrigan.   

Abstract

The purpose of this study was to explore local perceptions and experiences regarding vaccines in general and HIV vaccines and vaccine trials in the Dominican Republic. In-depth interviews were carried out with 25 participants representing two study groups: (1) individuals considered at high risk for HIV infection including female sex workers and male STI clinic attendees and (2) individuals considered at low risk of HIV infection including women and men recruited at a general outpatient clinic. Across the groups, participants often characterized vaccines in general as having both preventive and curative properties. In turn, one of the most salient concerns regarding the receipt of an HIV vaccine was the fear that one would be labelled 'HIV positive' and stigmatized, as the vaccine may be perceived as a cure for those already infected. These findings suggest the importance of individual and community level education to clarify the nature and mechanisms of the given HIV vaccine being tested. Social support and counselling services should also accompany HIV vaccine trials and distribution plans to assist individuals in determining if and how they communicate their participation and/or receipt of an HIV vaccine to others and manage potential negative social reactions.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17712690     DOI: 10.1080/09540120701203295

Source DB:  PubMed          Journal:  AIDS Care        ISSN: 0954-0121


  11 in total

1.  Balancing collective responsibility, individual opportunities and risks: a qualitative study on how police officers reason around volunteering in an HIV vaccine trial in Dar es Salaam, Tanzania.

Authors:  Edith A M Tarimo; Anna Thorson; Thecla W Kohi; Joachim Mwami; Muhammad Bakari; Eric Sandström; Asli Kulane
Journal:  BMC Public Health       Date:  2010-05-28       Impact factor: 3.295

2.  Drug users' willingness to encourage social, sexual, and drug network members to receive an HIV vaccine: a social network analysis.

Authors:  A M Young; R J DiClemente; D S Halgin; C E Sterk; J R Havens
Journal:  AIDS Behav       Date:  2014-09

3.  Willingness to volunteer in a Phase I/II HIV vaccine trial: a study among police officers in Dar es Salaam, Tanzania.

Authors:  Edith A M Tarimo; Anna Thorson; Muhammad Bakari; Joachim Mwami; Eric Sandström; Asli Kulane
Journal:  Glob Health Action       Date:  2009-08-07       Impact factor: 2.640

Review 4.  Stigma in the HIV/AIDS epidemic: a review of the literature and recommendations for the way forward.

Authors:  Anish P Mahajan; Jennifer N Sayles; Vishal A Patel; Robert H Remien; Sharif R Sawires; Daniel J Ortiz; Greg Szekeres; Thomas J Coates
Journal:  AIDS       Date:  2008-08       Impact factor: 4.177

5.  Feasibility of Identifying a Female Sex Worker Cohort at High Risk of HIV Infection in the Caribbean for HIV Vaccine Efficacy Trials: Longitudinal Results of HVTN 907.

Authors:  Marie M Deschamps; Barbara Metch; Cecilia A Morgan; Carmen D Zorilla; Yeycy Donastorg; Edith Swann; Dadaille Taina; Joseph Patrice; William J Pape
Journal:  J Acquir Immune Defic Syndr       Date:  2016-01-01       Impact factor: 3.731

6.  Motivations to participate in a Phase I/II HIV vaccine trial: A descriptive study from Dar es Salaam, Tanzania.

Authors:  E A M Tarimo; M Bakari; D C V Kakoko; T W Kohi; F Mhalu; E Sandstrom; A Kulane
Journal:  BMC Public Health       Date:  2016-02-24       Impact factor: 3.295

7.  The Influence of Community Members on Participation by Youth in an HIV Vaccine Trial in Tanzania.

Authors:  Theodora Mbunda; Edith A M Tarimo; Guerino Chalamilla; Muhammad Bakari; Eric Sandström; Asli Kulane
Journal:  PLoS One       Date:  2016-12-20       Impact factor: 3.240

8.  Acceptability of a hypothetical preventative HIV vaccine among people who use drugs in Vancouver, Canada.

Authors:  Taylor Fleming; Jenna Valleriani; Cara Ng; Lisa Maher; Will Small; Ryan McNeil
Journal:  BMC Public Health       Date:  2020-07-09       Impact factor: 3.295

9.  Design aspects of vaginal applicators that influence acceptance among target users.

Authors:  Alyssa J Bakke; Toral Zaveri; Molly J Higgins; Gregory R Ziegler; John E Hayes
Journal:  Sci Rep       Date:  2021-05-07       Impact factor: 4.379

10.  HIV vaccine acceptability among high-risk drug users in Appalachia: a cross-sectional study.

Authors:  April M Young; Ralph J DiClemente; Daniel S Halgin; Claire E Sterk; Jennifer R Havens
Journal:  BMC Public Health       Date:  2014-05-30       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.